Portfolio company
Sealonix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioabsorbable hemostatic sealant patches to control surgical bleeding for healthcare providers performing abdominopelvic and orthopaedic procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
ClotProtect
This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.
Confluent Surgical
The company develops and manufactures synthetic polymer-based sealants and adhesion barriers for surgical clinicians to prevent fluid leaks and post-operative complications during procedures.
Nanoflexion
Nanoflexion develops resorbable nanofiber surgical patches to prevent anastomotic leakage and adhesions in patients undergoing gastrointestinal surgery.
Cebiotex
This company develops nanofiber membranes that release anti-tumour agents at surgical sites for oncology patients.
ProFibrix
The company develops and manufactures powdered fibrin sealants for surgeons to control bleeding during and after surgical procedures.
